Logo for Isofol Medical

Isofol Medical Investor Relations Material

Latest events

Logo for Isofol Medical

Q3 2023

10 Nov, 2023
Logo for Isofol Medical

Q2 2023

22 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Segment Data
Access more data
Revenue by
Expenses by
Isofol Medical operates as a clinical stage biotech company that develops and commercializes oncology drugs. Its products include arfolitixorin, which is in phase 3 clinical trial for the treatment of colorectal cancer; pentosan sulfate sodium, which has completed a phase 2 clinical trial for ovarian cancer or recurrent bladder cancer indication; new chemical entities, preclinical NCEs; monoclonal antibodies, which are being investigated for immunotherapy treatment of different types of cancer.